Logo image of ALNSE.PA

NSE (ALNSE.PA) Stock Fundamental Analysis

Europe - EPA:ALNSE - FR0004065639 - Common Stock

42.7 EUR
0 (0%)
Last: 11/5/2025, 7:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ALNSE. ALNSE was compared to 46 industry peers in the Aerospace & Defense industry. While ALNSE has a great health rating, its profitability is only average at the moment. ALNSE has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ALNSE had positive earnings in the past year.
In the past year ALNSE had a positive cash flow from operations.
ALNSE had positive earnings in each of the past 5 years.
Of the past 5 years ALNSE 4 years had a positive operating cash flow.
ALNSE.PA Yearly Net Income VS EBIT VS OCF VS FCFALNSE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

1.2 Ratios

ALNSE has a Return On Assets (4.15%) which is comparable to the rest of the industry.
ALNSE has a Return On Equity (8.69%) which is comparable to the rest of the industry.
With a decent Return On Invested Capital value of 10.97%, ALNSE is doing good in the industry, outperforming 67.39% of the companies in the same industry.
ALNSE had an Average Return On Invested Capital over the past 3 years of 9.24%. This is in line with the industry average of 9.55%.
The last Return On Invested Capital (10.97%) for ALNSE is above the 3 year average (9.24%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.15%
ROE 8.69%
ROIC 10.97%
ROA(3y)4.86%
ROA(5y)5.44%
ROE(3y)9.24%
ROE(5y)10.68%
ROIC(3y)9.24%
ROIC(5y)10.98%
ALNSE.PA Yearly ROA, ROE, ROICALNSE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

1.3 Margins

ALNSE has a Profit Margin of 3.50%. This is comparable to the rest of the industry: ALNSE outperforms 41.30% of its industry peers.
In the last couple of years the Profit Margin of ALNSE has declined.
Looking at the Operating Margin, with a value of 6.85%, ALNSE is doing worse than 63.04% of the companies in the same industry.
ALNSE's Operating Margin has declined in the last couple of years.
ALNSE's Gross Margin of 43.87% is fine compared to the rest of the industry. ALNSE outperforms 69.57% of its industry peers.
In the last couple of years the Gross Margin of ALNSE has declined.
Industry RankSector Rank
OM 6.85%
PM (TTM) 3.5%
GM 43.87%
OM growth 3Y-10.36%
OM growth 5Y-11.66%
PM growth 3Y-17.04%
PM growth 5Y-14.59%
GM growth 3Y-13.53%
GM growth 5Y-7.43%
ALNSE.PA Yearly Profit, Operating, Gross MarginsALNSE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

8

2. Health

2.1 Basic Checks

ALNSE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ALNSE has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ALNSE has been increased compared to 5 years ago.
ALNSE has a better debt/assets ratio than last year.
ALNSE.PA Yearly Shares OutstandingALNSE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALNSE.PA Yearly Total Debt VS Total AssetsALNSE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 4.35 indicates that ALNSE is not in any danger for bankruptcy at the moment.
The Altman-Z score of ALNSE (4.35) is better than 78.26% of its industry peers.
The Debt to FCF ratio of ALNSE is 0.65, which is an excellent value as it means it would take ALNSE, only 0.65 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.65, ALNSE belongs to the best of the industry, outperforming 93.48% of the companies in the same industry.
ALNSE has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ALNSE (0.12) is better than 93.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 0.65
Altman-Z 4.35
ROIC/WACC1.36
WACC8.04%
ALNSE.PA Yearly LT Debt VS Equity VS FCFALNSE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.77 indicates that ALNSE should not have too much problems paying its short term obligations.
ALNSE has a Current ratio of 1.77. This is amongst the best in the industry. ALNSE outperforms 80.43% of its industry peers.
ALNSE has a Quick Ratio of 1.31. This is a normal value and indicates that ALNSE is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ALNSE (1.31) is better than 82.61% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.31
ALNSE.PA Yearly Current Assets VS Current LiabilitesALNSE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

6

3. Growth

3.1 Past

The earnings per share for ALNSE have decreased strongly by -12.26% in the last year.
ALNSE shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.31% yearly.
Looking at the last year, ALNSE shows a very strong growth in Revenue. The Revenue has grown by 34.51%.
ALNSE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.37% yearly.
EPS 1Y (TTM)-12.26%
EPS 3Y-3.88%
EPS 5Y-9.31%
EPS Q2Q%-59.8%
Revenue 1Y (TTM)34.51%
Revenue growth 3Y15.84%
Revenue growth 5Y6.37%
Sales Q2Q%16.05%

3.2 Future

ALNSE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.23% yearly.
Based on estimates for the next years, ALNSE will show a quite strong growth in Revenue. The Revenue will grow by 17.73% on average per year.
EPS Next Y25.09%
EPS Next 2Y29.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year33.7%
Revenue Next 2Y17.73%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALNSE.PA Yearly Revenue VS EstimatesALNSE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
ALNSE.PA Yearly EPS VS EstimatesALNSE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

ALNSE is valuated quite expensively with a Price/Earnings ratio of 37.46.
69.57% of the companies in the same industry are more expensive than ALNSE, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.13, ALNSE is valued a bit more expensive.
ALNSE is valuated rather expensively with a Price/Forward Earnings ratio of 22.78.
Based on the Price/Forward Earnings ratio, ALNSE is valued a bit cheaper than 78.26% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ALNSE to the average of the S&P500 Index (22.35), we can say ALNSE is valued inline with the index average.
Industry RankSector Rank
PE 37.46
Fwd PE 22.78
ALNSE.PA Price Earnings VS Forward Price EarningsALNSE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

86.96% of the companies in the same industry are more expensive than ALNSE, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ALNSE is valued cheaper than 95.65% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.81
EV/EBITDA 12.59
ALNSE.PA Per share dataALNSE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

ALNSE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ALNSE's earnings are expected to grow with 29.23% in the coming years.
PEG (NY)1.49
PEG (5Y)N/A
EPS Next 2Y29.23%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

ALNSE has a yearly dividend return of 0.62%, which is pretty low.
Compared to an average industry Dividend Yield of 1.07, ALNSE has a dividend in line with its industry peers.
With a Dividend Yield of 0.62, ALNSE pays less dividend than the S&P500 average, which is at 2.39.
Industry RankSector Rank
Dividend Yield 0.62%

5.2 History

The dividend of ALNSE is nicely growing with an annual growth rate of 22.60%!
Dividend Growth(5Y)22.6%
Div Incr Years2
Div Non Decr Years5
ALNSE.PA Yearly Dividends per shareALNSE.PA Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

21.90% of the earnings are spent on dividend by ALNSE. This is a low number and sustainable payout ratio.
ALNSE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP21.9%
EPS Next 2Y29.23%
EPS Next 3YN/A
ALNSE.PA Yearly Income VS Free CF VS DividendALNSE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M
ALNSE.PA Dividend Payout.ALNSE.PA Dividend Payout, showing the Payout Ratio.ALNSE.PA Dividend Payout.PayoutRetained Earnings

NSE

EPA:ALNSE (11/5/2025, 7:00:00 PM)

42.7

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)07-23 2025-07-23
Earnings (Next)N/A N/A
Inst Owners21.02%
Inst Owner ChangeN/A
Ins Owners64.28%
Ins Owner ChangeN/A
Market Cap144.33M
Revenue(TTM)103.56M
Net Income(TTM)3.63M
Analysts86.67
Price Target65.28 (52.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.62%
Yearly Dividend0.25
Dividend Growth(5Y)22.6%
DP21.9%
Div Incr Years2
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)28%
PT rev (3m)27.24%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 37.46
Fwd PE 22.78
P/S 1.39
P/FCF 12.81
P/OCF 10.16
P/B 3.46
P/tB 3.94
EV/EBITDA 12.59
EPS(TTM)1.14
EY2.67%
EPS(NY)1.87
Fwd EY4.39%
FCF(TTM)3.33
FCFY7.81%
OCF(TTM)4.2
OCFY9.84%
SpS30.64
BVpS12.35
TBVpS10.83
PEG (NY)1.49
PEG (5Y)N/A
Graham Number17.8
Profitability
Industry RankSector Rank
ROA 4.15%
ROE 8.69%
ROCE 14.62%
ROIC 10.97%
ROICexc 15.46%
ROICexgc 18.16%
OM 6.85%
PM (TTM) 3.5%
GM 43.87%
FCFM 10.88%
ROA(3y)4.86%
ROA(5y)5.44%
ROE(3y)9.24%
ROE(5y)10.68%
ROIC(3y)9.24%
ROIC(5y)10.98%
ROICexc(3y)11.65%
ROICexc(5y)13.8%
ROICexgc(3y)13.37%
ROICexgc(5y)15.81%
ROCE(3y)12.32%
ROCE(5y)14.64%
ROICexgc growth 3Y-2.2%
ROICexgc growth 5Y-7.13%
ROICexc growth 3Y-2.56%
ROICexc growth 5Y-7.79%
OM growth 3Y-10.36%
OM growth 5Y-11.66%
PM growth 3Y-17.04%
PM growth 5Y-14.59%
GM growth 3Y-13.53%
GM growth 5Y-7.43%
F-Score5
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 0.65
Debt/EBITDA 0.49
Cap/Depr 86.46%
Cap/Sales 2.83%
Interest Coverage 41.27
Cash Conversion 135.38%
Profit Quality 310.87%
Current Ratio 1.77
Quick Ratio 1.31
Altman-Z 4.35
F-Score5
WACC8.04%
ROIC/WACC1.36
Cap/Depr(3y)97.38%
Cap/Depr(5y)100.98%
Cap/Sales(3y)3.76%
Cap/Sales(5y)3.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.26%
EPS 3Y-3.88%
EPS 5Y-9.31%
EPS Q2Q%-59.8%
EPS Next Y25.09%
EPS Next 2Y29.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)34.51%
Revenue growth 3Y15.84%
Revenue growth 5Y6.37%
Sales Q2Q%16.05%
Revenue Next Year33.7%
Revenue Next 2Y17.73%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.7%
EBIT growth 3Y3.84%
EBIT growth 5Y-6.03%
EBIT Next Year110.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y363.17%
FCF growth 3Y-2.62%
FCF growth 5Y6.82%
OCF growth 1Y106.8%
OCF growth 3Y-2.36%
OCF growth 5Y8.53%

NSE / ALNSE.PA FAQ

What is the fundamental rating for ALNSE stock?

ChartMill assigns a fundamental rating of 6 / 10 to ALNSE.PA.


What is the valuation status of NSE (ALNSE.PA) stock?

ChartMill assigns a valuation rating of 5 / 10 to NSE (ALNSE.PA). This can be considered as Fairly Valued.


How profitable is NSE (ALNSE.PA) stock?

NSE (ALNSE.PA) has a profitability rating of 4 / 10.


What are the PE and PB ratios of NSE (ALNSE.PA) stock?

The Price/Earnings (PE) ratio for NSE (ALNSE.PA) is 37.46 and the Price/Book (PB) ratio is 3.46.


Can you provide the expected EPS growth for ALNSE stock?

The Earnings per Share (EPS) of NSE (ALNSE.PA) is expected to grow by 25.09% in the next year.